Iovance Biotherapeutics, Inc. 0JDK.L
0JDK.L
Iovance Biotherapeutics, Inc. 0IIM.L
Esperion Therapeutics, Inc. 0IV3.L
Geron Corporation 0HX7.L
Adicet Bio, Inc. 0IFK.L
Editas Medicine, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0HFR.L
Anavex Life Sciences Corp. 0K3W.L
Myriad Genetics, Inc.
Iovance Biotherapeutics, Inc. 0IIM.L
Esperion Therapeutics, Inc. 0IV3.L
Geron Corporation 0HX7.L
Adicet Bio, Inc. 0IFK.L
Editas Medicine, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0HFR.L
Anavex Life Sciences Corp. 0K3W.L
Myriad Genetics, Inc.
Performance
| Periode | 0JDK.L | 0IIM.L | 0IV3.L | 0HX7.L | 0IFK.L | 0R1D.L | 0J4V.L | 0H8T.L | 0HFR.L | 0K3W.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -32.92 % | 164.43 % | 2.24 % | 102.02 % | 191.34 % | -4.03 % | -29.51 % | 63.97 % | 6.24 % | -2.32 % |
| YTD | -72.90 % | 14.45 % | -63.67 % | 5.51 % | 170.07 % | -35.64 % | -20.86 % | -25.12 % | -20.87 % | -44.35 % |
| 1Y | -78.07 % | 32.55 % | -68.30 % | -27.14 % | 17.09 % | -26.18 % | -27.12 % | 57.19 % | 73.09 % | -69.00 % |
| 3Y | -76.12 % | -67.07 % | -43.88 % | -93.22 % | -69.52 % | -85.44 % | -64.05 % | -88.43 % | -15.34 % | -62.17 % |
| 5Y | -91.05 % | -40.85 % | -23.76 % | -92.51 % | -81.38 % | -88.68 % | -93.87 % | -73.10 % | -48.28 % | -73.78 % |
| 10Y | -91.05 % | -40.85 % | -34.71 % | -92.51 % | -81.38 % | -88.68 % | -94.69 % | -92.25 % | -48.28 % | -81.49 % |
| From the beginning | -91.05 % | -40.85 % | -34.71 % | -92.51 % | -81.38 % | -88.68 % | -94.69 % | -92.25 % | -48.28 % | -81.49 % |